Cala Receives Pricing from CMS for Cala TAPS Therapy to Expand Medicare Patient Access
Benefit category designation and payment determination expands patient access to the only FDA-cleared non-invasive targeted therapy for hand tremor SAN MATEO, Calif.–(BUSINESS WIRE)–Cala, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has set a payment determination and benefit … [Read more…]
